Cell & Gene

Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy

The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...

 April 26, 2024 | News

Thermo Fisher Scientific Establishes New Frontiers in Indonesia with Jakarta Office Opening and Strategic Partnerships

Thermo Fisher Scientific, the world leader in serving science, opens its inaugural office in Jakarta, Indonesia, marking a pivotal step in its strategic ex...

 April 25, 2024 | News

Waters Corporation Launches Advanced GTxResolve™ Premier SEC Columns for Gene Therapy Development

New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene...

 April 23, 2024 | News

Artiva Biotherapeutics Initiates First U.S. Trial of Allogeneic NK Cell Therapy for Lupus Nephritis

Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-bas...

 April 18, 2024 | News

SCG Cell Therapy and A*STAR Launch Joint Labs to Advance Cellular Immunotherapy in Singapore

Collaboration aims to develop scalable GMP-grade iPSC manufacturing processes and therapeutic candidates to facilitate research leading to translation of...

 April 18, 2024 | News

CSafe Launches Cryogenic Dewars for Cell and Gene Therapies

CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new l...

 April 17, 2024 | News

IASO Bio's BCMA CAR-T Therapy Eque-cel Receives FDA Approval for U.S. Clinical Trials in Myasthenia Gravis

 IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell ...

 April 08, 2024 | News

YolTech Therapeutics Initiates Clinical Trial for Gene Editing Treatment YOLT-101 Targeting Familial Hypercholesterolemia

YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being develope...

 April 03, 2024 | News

IASO Bio Gains NMPA Approval for Multiple Myeloma Treatment IND

IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, anno...

 April 01, 2024 | News

EditCo Bio Launches with Acquisition of Synthego's Cell Engineering Divisions to Boost CRISPR Market Innovations

EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego's engineered cell solutions and enhanced guide RNA business. ...

 March 28, 2024 | News

Integrated DNA Technologies Launches Innovative Custom Vector Onboarding Tool to Streamline Gene Synthesis

Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced  the expansion of its gene synthesis services with the launch of a...

 March 28, 2024 | News

Nanoscope Therapeutics Achieves Breakthrough in Retinitis Pigmentosa Treatment with MCO-010 Gene Therapy

Nanoscope Therapeutics, a pioneering biotechnology firm, unveiled groundbreaking results from the Phase 2b RESTORE trial of MCO-010...

 March 27, 2024 | News

Andelyn Biosciences and Grace Science Partner on Gene Therapy for Rare Disease

 Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has par...

 March 26, 2024 | News

NeuExcell Therapeutics Launches Pioneering Gene Therapy Trial for Glioblastoma Patients

NeuExcell Therapeutics, a leading biotechnology company focused on in vivo neural regenerative therapies, announces the successful dosing of the ...

 March 22, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close